Department of Genomic and Systems Reproductive Medicine, IVI-RMA (Instituto Valenciano de Infertilidad, Reproductive Medicine Associates) IVI Foundation, Valencia, Spain; Department of Pediatrics, Obstetrics and Gynaecology, University of Valencia, Valencia, Spain.
Department of Genomic and Systems Reproductive Medicine, IVI-RMA (Instituto Valenciano de Infertilidad, Reproductive Medicine Associates) IVI Foundation, Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, University of Valencia, Valencia, Spain.
Fertil Steril. 2020 Jun;113(6):1261-1274. doi: 10.1016/j.fertnstert.2020.01.025.
To determine the molecular functions of genes exhibiting altered expression in the endometrium of women with uterine disorders affecting fertility.
Retrospective analysis integrating case and control data from multiple cohorts with endometrium gene expression in women with uterine disorders.
Infertility research department affiliated with a university hospital.
PATIENT(S): Two hundred and forty women, 121 of whom were controls, 119 of whom had endometrial adenocarcinoma (ADC), recurrent implantation failure (RIF), recurrent pregnancy loss (RPL), or stage II-IV endometriosis.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Genomewide gene expression and altered molecular functions in the endometrium of each uterine disorder.
RESULT(S): Using robust analysis methods, we identified statistically significantly altered endometrial functions in all the uterine disorders. Cell cycle alterations were shared among all the pathologies investigated. Endometriosis was characterized by the down-regulation of ciliary processes. Among the endometriosis, ADC, and RIF samples, mitochondrial dysfunction and protein degradation were shared dysregulated processes. In addition, RPL had the most distinct functional profile, and 95% of affected functions were down-regulated.
CONCLUSION(S): The most robust functions dysregulated in the endometrium of patients with uterine disorders across sample cohorts implicated an endometrial factor at the gene expression level. This shared endometrial factor affects endometrial receptivity processes.
确定在影响生育能力的子宫疾病的女性子宫内膜中表达改变的基因的分子功能。
对来自多个队列的病例和对照数据进行回顾性分析,这些队列中包含有子宫疾病女性的子宫内膜基因表达数据。
大学附属医院的不孕研究部门。
240 名女性,其中 121 名为对照,119 名为子宫内膜腺癌(ADC)、复发性着床失败(RIF)、复发性流产(RPL)或 II-IV 期子宫内膜异位症患者。
无。
每种子宫疾病患者子宫内膜的全基因组基因表达和改变的分子功能。
使用稳健的分析方法,我们确定了所有子宫疾病中子宫内膜功能发生统计学显著改变。细胞周期改变在所有研究的病理中都存在。子宫内膜异位症的特征是纤毛过程下调。在子宫内膜异位症、ADC 和 RIF 样本中,线粒体功能障碍和蛋白质降解是共享的失调过程。此外,RPL 具有最独特的功能谱,95%受影响的功能下调。
在来自不同样本队列的患有子宫疾病患者的子宫内膜中失调最明显的功能暗示了基因表达水平上的子宫内膜因子。这种共享的子宫内膜因子影响子宫内膜的接受能力过程。